4.6 Article

Silica microspheres are superior to polystyrene for microvesicle analysis by flow cytometry

Journal

THROMBOSIS RESEARCH
Volume 135, Issue 5, Pages 1000-1006

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.thromres.2015.02.011

Keywords

Microvesicles; Cell-derived microparticles; Silica microspheres; Polystyrene microspheres; Platelets

Funding

  1. U.S. Army Medical Research and Materiel Command
  2. National Research Council fellowship

Ask authors/readers for more resources

Background: Cell-derived microvesicles (MVs) in biological fluids are studied for their potential role in pathological conditions. Flow cytometry is used to characterize MVs. Polystyrene microspheres are often used in flow cytometry to distinguish MV from cells by setting a 1-mu mMV gate in a side-scatter (SSC) vs. forward-scatter (FSC) dot plot. Polystyrene microspheres, however, exhibit higher FSC and SSC than MVs of equal size. Consequently, some platelets are included within the MV gate, which incorrectly increases the reported percentage of platelet-derived MVs. Silica microspheres exhibit FSC that is closer to that of cellular vesicles and, therefore, should permit more accurate discrimination of MV from platelets. Objective: Compare silica with polystyrene microspheres to calibrate flow cytometers for definition of MV population and estimation of MV sizes. Methods: Silica and polystyrene microspheres of various sizes were used in flow cytometry assays to define MV populations and determine platelet and MV sizes in human plasma samples. Sizes determined by flow cytometry were compared to sizes determined by resistive pulse sensing (RPS) method. Results/Conclusion: Use of 1.0-mu m polystyrene microspheres to define the upper MV gate produced a median platelet contamination of 16.53% (8.24, 20.98) of the MV population; whereas, use of 1.0-mu m silica microspheres excluded platelet events completely. Calibration with silica microspheres resulted in significantly better estimation of MV diameter than calibration with polystyrene microspheres. We conclude that silica microspheres are superior to polystyrene microspheres as standards to define MV populations without platelet contamination and to determine MV sizes by flow cytometry for a given cytometer. (C) 2015 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
Article Hematology

Adhesive properties of plasma-circulating and platelet-derived microvesicles from healthy individuals

E. O. Artemenko, S. I. Obydennyi, K. S. Troyanova, G. A. Novichkova, D. Y. Nechipurenko, M. A. Panteleev

Summary: In this study, we investigated the adhesive properties of circulating plasma-derived and platelet-derived microvesicles (MVs) and their potential role in thrombus growth. The results showed that both types of MVs weakly bound fibrinogen but did not stably adhere to immobilized fibrinogen. Moreover, the presence of these MVs did not significantly affect thrombus formation. Therefore, MVs present in the plasma of healthy individuals are unlikely to directly contribute to thrombus formation under arterial flow conditions.

THROMBOSIS RESEARCH (2024)

Letter Hematology

Recent monthly mortality for pulmonary embolism in the US

Giuseppe Lippi, Camilla Mattiuzzi, Emmanuel J. Favaloro

THROMBOSIS RESEARCH (2024)

Article Hematology

Exploration of rotational thromboelastometry (ROTEM) to characterize the coagulation profiles of newly diagnosed pediatric leukemia patients

Marium Malik, Maha Al-Ghafry, Abraham Haimed, Julia Su, Maribel Lema, Linda Shore-Lessersson, Suchitra S. Acharya

Summary: This study analyzed and evaluated leukemia-associated coagulopathy in newly diagnosed pediatric leukemia patients using CCTs and ROTEM. The results showed that fibrinogen and platelets played a significant role in causing coagulopathies in this population. This suggests the utility of using CCTs and ROTEM in the pediatric population to evaluate hemostatic function and guide blood product replacement.

THROMBOSIS RESEARCH (2024)

Review Hematology

Thrombotic triad in microgravity

Mohammad M. Elahi, Alexandra N. Witt, Edward L. G. Pryzdial, Paul B. McBeth

Summary: Thrombotic disease may be underdiagnosed in microgravity conditions, and the underlying factors are still poorly understood. A case of internal jugular vein thrombosis was recently diagnosed in a low-risk female astronaut, and six out of ten additional crew members showed risk factors for jugular venous flow. Observations in space and studies on Earth suggest that microgravity affects blood flow, coagulation, and vascular function.

THROMBOSIS RESEARCH (2024)

Review Hematology

Comparison of important factors to patients recovering from pulmonary embolism and items covered in patient-reported outcome measures: A mixed-methods systematic review

Stian Ingemann-Molden, Christina Krogner Caspersen, Nanna Rolving, Anette Arbjerg Hojen, Frederikus A. Klok, Erik L. Grove, Barbara Cristina Brocki, Jane Andreasen

Summary: This study found that no single PROM covered all aspects considered important by PE patients. PROMs recommended in the ICHOM core set covered most aspects, but worrisome thoughts, hypervigilance around symptoms, and uncertainty of illness were not covered.

THROMBOSIS RESEARCH (2024)

Article Hematology

Driver gene KRAS aggravates cancer-associated stroke outcomes

Haomin Yan, Tsutomu Sasaki, Yasufumi Gon, Kumiko Nishiyama, Hideaki Kanki, Hideki Mochizuki

Summary: The incidence of cancer-associated stroke has increased with the prolonged survival times of cancer patients. In this study, the researchers focused on the driver gene KRAS and found that KRAS mutations exacerbated neurological deficits after stroke and promoted tumor growth. They also identified the upregulation of pro-inflammatory responses and the promotion of STAT3 phosphorylation in mice with KRAS mutations. Additionally, the researchers found that colorectal cancer patients with stroke onset within 3 months after cancer diagnosis had a worse prognosis.

THROMBOSIS RESEARCH (2024)

Letter Hematology

Identification of two de novo variants causing inherited antithrombin deficiency by quantitative analysis of variant alleles

Tomoki Togashi, Satomi Nagaya, Makiko Meguro-Horike, Haruto Matsumoto, Yuta Imai, Koichi Yamaguchi, Yoshinari Fujii, Haruka Moriya, Yuika Kikuchi, Ibuki Yasuda, Shin-ichi Horike, Eriko Morishita

THROMBOSIS RESEARCH (2024)

Article Hematology

Shock score for prediction of clinical outcomes among stable patients with acute symptomatic pulmonary embolism

Marta Najarro, Winnifer Briceno, Carmen Rodriguez, Alfonso Muriel, Sara Gonzalez, Ana Castillo, Ignacio Jara, Parth Rali, Catalin Toma, Behnood Bikdeli, David Jimenez

Summary: The CPES score is a useful tool in identifying the risk of hemodynamic deterioration in normotensive patients with acute PE, with acceptable C-statistic, excellent specificity, and low positive predictive value.

THROMBOSIS RESEARCH (2024)

Article Hematology

Trimethylamine-N-oxide (TMAO) and basic fibroblast growth factor (bFGF) are possibly involved in corticosteroid resistance in adult patients with immune thrombocytopenia

Lei Liu, Huifang Xu, Jian Wang, Haiyan Wang, Saisai Ren, Qian Huang, Mingyan Zhang, Hui Zhou, Chunyan Yang, Lu Jia, Yu Huang, Hao Zhang, Yanling Tao, Ying Li, Yanan Min

Summary: This study investigated the gut microbiota metabolites and cytokines, chemokines, and growth factors in patients with ITP and found their association with treatment responsiveness. The findings suggest that imbalanced secretion of cyto(chemo)kins/growth factors and inadequate levels of TMAO are characteristic of patients with ITP.

THROMBOSIS RESEARCH (2024)

Article Hematology

Safety of fixed-dose heparin titration boluses in underweight patients

Roxanne Mcknight, Mohammad Salameh, Lee Ann Jones, Greta Anton, Lindsay Carter

Summary: This study evaluated the safety of fixed-dose heparin titration boluses in underweight patients with VTE. The results showed that although underweight patients required more frequent holding of heparin, there was no significant increase in bleeding risk.

THROMBOSIS RESEARCH (2024)